科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 未找到姓氏以该字母开头的医生 A
  2. 查找姓氏以该字母开头的医生 B
  3. 未找到姓氏以该字母开头的医生 C
  4. 查找姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 未找到姓氏以该字母开头的医生 F
  7. 未找到姓氏以该字母开头的医生 G
  8. 查找姓氏以该字母开头的医生 H
  9. 未找到姓氏以该字母开头的医生 I
  10. 查找姓氏以该字母开头的医生 J
  11. 未找到姓氏以该字母开头的医生 K
  12. 查找姓氏以该字母开头的医生 L
  13. 查找姓氏以该字母开头的医生 M
  14. 查找姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 查找姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 未找到姓氏以该字母开头的医生 R
  19. 未找到姓氏以该字母开头的医生 S
  20. 未找到姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 未找到姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

  1. Alex G. Boutselis, M.D.

    Alex G. Boutselis, M.D.

    1. Radiologist
    1. Phoenix, AZ
    擅长领域:

    Emergency care, Abdominal CT scan, Trauma care, Thyroid scan, X-ray, MRI, CT scan, Ultrasound, Bone scan, Nuclear medic...ine scan, Positron emission tomography scan, Focused ultrasound, Abdominal ultrasound, Brain MRI , Chest x-ray, Brain CT scan, CT angiogram, Doppler ultrasound, Stroke, Traumatic brain injury, Thyroid disease, Pneumothorax, Pulmonary embolism, Pneumonia, Diverticulitis, Gastrointestinal bleeding, Small bowel obstruction, Appendicitis, Infection, Pelvis fracture, Spinal compression fracture, Traumatic injury, Pediatric trauma, Bone metastasis, Intracranial hemorrhage, Head trauma, Gastrointestinal perforation, Metastatic spinal cord compression, Pathologic fracture, Cancer treatment related morbidity, Abdominal wall injury, Abdominal injury, Chest injury, Traumatic spine injury

  2. Jolanta M. Durski, M.D.

    Jolanta M. Durski, M.D.

    1. Nuclear Medicine Specialist
    1. Rochester, MN
    擅长领域:

    Positron emission tomography scan, Radiopharmaceutical therapy, Neuroendocrine tumor, Thyroid cancer, Pancreatic neuroe...ndocrine tumor

  3. Christopher H. Hunt, M.D.

    Christopher H. Hunt, M.D.

    1. Radiologist
    2. Neurologist
    1. Rochester, MN
    擅长领域:

    PET/CT scan, Positron emission tomography scan, Epilepsy

  4. Manoj K. Jain, M.D.

    Manoj K. Jain, M.D.

    1. Radiologist
    2. Nuclear Medicine Specialist
    1. Jacksonville, FL
    擅长领域:

    PET/MRI scan, Thyroid scan, Nuclear medicine scan, Positron emission tomography scan, Neuroendocrine tumor, Pancreatic ...neuroendocrine tumor

  5. Val Lowe, M.D.

    Val Lowe, M.D.

    1. Nuclear Medicine Specialist
    1. Rochester, MN
    擅长领域:

    PET/MRI scan, Positron emission tomography scan

  6. Francisco J. Maldonado, M.D.

    Francisco J. Maldonado, M.D.

    1. Radiologist
    2. Nuclear Medicine Specialist
    1. Rochester, MN
    擅长领域:

    Breast biopsy, Mammogram, Breast MRI, SPECT scan, Positron emission tomography scan, Contrast-enhanced mammogram, Radio...pharmaceutical therapy

  7. Ba D. Nguyen, M.D.

    Ba D. Nguyen, M.D.

    1. Radiologist
    1. Phoenix, AZ
    擅长领域:

    MRI, CT scan, Ultrasound, Nuclear medicine scan, Positron emission tomography scan, Nuclear stress test, Breast cancer,... Hyperparathyroidism, Melanoma

  8. Anshuman J. Panda, Ph.D.

    Anshuman J. Panda, Ph.D.

    1. Medical Physicist
    1. Phoenix, AZ
    擅长领域:

    Radiation therapy, MRI, Positron emission tomography scan

  9. Robert A. Pooley, Ph.D.

    Robert A. Pooley, Ph.D.

    1. Medical Physicist
    1. Jacksonville, FL
    擅长领域:

    MRI, Positron emission tomography scan

研究

妙佑医疗国际的放射科医生及其他医务人员致力于研究如何利用 PET 扫描来实现疾病早期筛查并制定治疗方案。2012 年,妙佑医疗国际获得美国食品药品管理局批准,可制备并提供胆碱 C-11 注射剂。胆碱 C-11 是正电子发射体层成像(PET)期间使用的显像剂,有助于排查前列腺癌是否复发(也称为复发性前列腺癌)。妙佑医疗国际是首家获得 FDA 批准可生产胆碱 C-11 的医疗机构。

文献著述

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗作者在 PET 扫描领域的著述目录。

Research Profiles

Sept. 24, 2026
  1. PET/CT. RadiologyInfo. https://www.radiologyinfo.org/en/info/PET. Accessed March 18, 2026.
  2. Fact sheet: What is PET? Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/What-is-PET.aspx. Accessed March 18, 2026.
  3. Unterrainer M, et al. Recent advances of PET imaging in clinical radiation oncology. Radiation Oncology. 2020; doi:10.1186/s13014-020-01519-1.
  4. Adam A, et al., eds. Functional and molecular imaging for personalized medicine in oncology. In: Grainger and Allison's Diagnostic Radiology. 7th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed March 26, 2026.
  5. ACR-SPR practice parameters for performing FDG-PET/CT in oncology. American College of Radiology. https://gravitas.acr.org/PPTS. Accessed March 18, 2026.
  6. Cervical cancer. RadiologyInfo. https://www.radiologyinfo.org/en/info/cervicalcancer. Accessed March 27, 2026.
  7. Singnurkar A, et al. Head-to-head comparison of the diagnostic performance of FDG PET/CT and FDG PET/MRI in patients with cancer: A systematic review and meta-analysis. American Journal of Roentgenology. 2024; doi:10.2214/AJR.24.31519.
  8. Choline C‑11 (approval letter). New Drug Application 203155. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203155. Accessed March 30, 2026.
  9. Ferri FF. Diagnostic imaging. In: Ferri's Best Test: A Practical Guide to Clinical Laboratory Medicine and Diagnostic Imaging. 5th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed March 26, 2026.
  10. Gelardi F, et al. Match point: Nuclear medicine imaging for recurrent thyroid cancer in TENIS syndrome-systematic review and meta-analysis. Journal of Clinical Medicine. 2024; doi:10.3390/jcm13185362.
  11. Datta D, et al. Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: A systemic review and meta-analysis. Annals of Nuclear Medicine. 2024; doi:10.1007/s12149-024-01934-4.
  12. Verger A, et al. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: Version 1.0. European Journal of Nuclear Medicine and Molecular Imaging. 2025; doi:10.1007/s00259-024-07038-5.
  13. Carlson DM, et al. Baseline characteristics and use of pretherapeutic 18 F-fluorodeoxyglucose-PET for pancreatic cancer. Journal of the American College of Surgeons. 2024; doi:10.1097/XCS.0000000000001059.
  14. Evangelista L, et al. The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: A systematic literature review. Annals of Nuclear Medicine. 2021; doi:10.1007/s12149-021-01629-0.
  15. PSMA PET scan for prostate cancer. Mayo Clinic. https://www.mayoclinic.org/tests-procedures/psma-pet-scan/about/pac-20582225. Accessed March 27, 2026.
  16. Fendler WP, et al. PSMA PET/CT: Joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. European Journal of Nuclear Medicine and Molecular Imaging. 2023; doi:10.1007/s00259-022-06089-w.
  17. Radiation dose. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/safety-xray. Accessed March 27, 2026.
  18. Voter AF, et al. A practical guide to the pearls and pitfalls of PSMA PET imaging. Seminars in Nuclear Medicine. 2023; doi:10.1053/j.semnuclmed.2023.11.001.
  19. Samim A, et al. SUV normalisation and reference tissue selection for [18F]mFBG PET-CT in paediatric and adult patients. European Journal of Nuclear Medicine and Molecular Imaging. 2025; doi:10.1007/s00259-025-07242-x.
  20. Choline C-11 PET scan. Mayo Clinic. https://www.mayoclinic.org/tests-procedures/choline-c-11-pet-scan/about/pac-20384628. Accessed March 30, 2026.
  21. FDA approves 11C-choline for PET in prostate cancer. Journal of Nuclear Medicine. 2012; 53:11N.

正电子发射体层成像(PET)扫描